This page shows the latest OAB news and features for those working in and with pharma, biotech and healthcare.
If approved, it would become the first new prescription drug in nearly a decade for OAB, claims Urovant. ... If approved by the FDA, [vibegron] could provide an exciting next-generation treatment option for patients suffering from OAB,” he added.
Urovant Sciences has licensed a novel gene therapy for patients with overactive bladder (OAB) symptoms who have failed oral pharmacologic therapy. ... hMaxi-K has been evaluated in two phase I studies in OAB patients including a small phase Ib clinical
Urovant aims to investigate the drug’s use in overactive bladder (OAB), as well as another trial in OAB patients with benign prostatic hyperplasia, plus a third trial in patients with
OAB). This review will be taken into consideration by the Federal Joint Committee (GBA), which will then recommend on whether the drug should be reimbursed on Germany's healthcare system. ... The decision is in contrast to the positive guidance from the
The campaign is for overactive bladder (OAB) drug Myrbetriq shows an untreated bladder character constantly interrupting a woman as she goes about her daily activities (see video above or on YouTube). ... The new campaign is aimed at women aged 45-69
Urology is a core product franchise for Astellas, with its standalone Harnal (tamsulosin) product for BPH and overactive bladder (OAB) therapy Vesicare (solifenacin) bringing in sales of 67bn yen and 87bn ... The company has already added to its OAB
More from news
Approximately 1 fully matching, plus 13 partially matching documents found.
In Europe we have been launching a product almost every single year,” notes Ken, pointing to products such as the overactive bladder (OAB) drug Betmiga (mirabegron) - the first of a new ... class of OAB treatments to emerge in over 30 years, the
For example, we are a GCL in urology; we have Vesicare, which has 40 per cent market share in the overactive bladder (OAB) market. ... From an OAB perspective, we support the Bladder and Bowel Foundation here in the UK, which provides a patient advice
Nearly one in five people in the UK over 40 have an overactive bladder (OAB) and live with the urgent need to go to the toilet. ... The campaign therefore needed to encourage people to set aside embarrassment, speak up about OAB and seek help.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
As Sabus leaves from the US, Astellas has promoted Lynn Fenicchia Gerber (pictured left) to US vice president, primary care, where she will lead sales efforts for the OAB, anti-fungal,
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Other emotive projects OAB Health Economics won silver in the Craft Award – Mobile and Diabetes Voyager won bronze in the Innovation Award – Pushing Boundaries. ... To get more details about Decisions in Time, OAB Health Economics,
Along with emotive projects like Diabetes Voyager and OAB Health Economics and Neil Kumar being nominated for Account Manager of the Year, emotive is a finalist for a total of six
OAB Health Economics app has been nominated in the Craft Award – Mobile category. -
Decisions in Time and the OAB Health Economics app.
Craft Award – Mobile for OAB Health Economics.
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...